Preferred Name |
oritavancin |
|
Synonyms |
LY333328 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C100708 |
|
altLabel |
LY333328 LY-333328 Orbactiv LY 333328 (4''R)-22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabinohexopyranosyl)-N3''-(p-(p-chlorophenyl)benzyl)vancomycin |
|
cui |
C0391524 C3852779 C1144403 |
|
Has mapping qualifier | ||
HM |
D014640/Q000031 D000077427 |
|
Inverse of RB |
PUG62FRZ2E |
|
isa | ||
LT |
TRD |
|
Mapped to | ||
MDA |
20140808 |
|
MeSH Frequency |
241 |
|
MMR |
20220722 |
|
notation |
C100708 |
|
PA |
D000900 |
|
PI |
*ANTI-BACTERIAL AGENTS (1996-2005) *GLYCOPEPTIDES (2006-2018) |
|
prefLabel |
oritavancin |
|
SC |
1 |
|
SRC |
J Antibiot (Tokyo) 1996 Jun;49(6):575-81 |
|
TERMUI |
T001122662 T294247 T000864039 T294246 T518799 T591675 |
|
TH |
NLM (1996) NLM (2002) NLM (2004) FDA SRS (2017) FDA SRS (2014) INN (19XX) NLM (2014) |
|
tui |
T109 T195 T116 |
Create mapping